Insider Transactions

What Biohaven Pharmaceutical Holding Co Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Gentile Kimberly	SVP, Clinical Operations	Oct 03	Disposition to Issuer · D	−11,653	$148.50	−$1.73M	0
Jones William A Jr	CCO-Migraine & Common Disease	Oct 03	Disposition to Issuer · D	−14,226	$148.50	−$2.11M	0
Bailey Gregory	Director	Oct 03	Disposition to Issuer · D	−2,583,658	$148.50	−$384M	0
Coric Vlad	Chief Executive Officer	Oct 03	Disposition to Issuer · D	−498,261	$148.50	−$74M	0
Coric Vlad	Chief Executive Officer	Oct 03	Disposition to Issuer · D	−19,130	$148.50	−$2.84M	498,261
Coric Vlad	Chief Executive Officer	Oct 03	Disposition to Issuer · D	−313,500	$148.50	−$46.6M	517,391
Coric Vlad	Chief Executive Officer	Oct 03	Disposition to Issuer · D	−92,050	$148.50	−$13.7M	830,891
Hugin Robert J	Director	Oct 03	Disposition to Issuer · D	−2,900	$148.50	−$431K	0
Childs John W	Director	Oct 03	Disposition to Issuer · D	−10,000	$148.50	−$1.49M	0
Childs John W	Director	Oct 03	Disposition to Issuer · D	−3,025,001	$148.50	−$449M	0
Engelhart James	Strategic Advisor	Oct 03	Disposition to Issuer · D	−15,900	$148.50	−$2.36M	0
Stock Elyse	Chief Medical Officer	Oct 03	Disposition to Issuer · D	−5,374	$148.50	−$798K	0
Stock Elyse	Chief Medical Officer	Oct 03	Disposition to Issuer · D	−11,090	$148.50	−$1.65M	0
Clark George C.	VP, Chief Accounting Officer	Oct 03	Disposition to Issuer · D	−4,292	$148.50	−$637K	0
Conway Charles	Chief Scientific Officer	Oct 03	Disposition to Issuer · D	−22,362	$148.50	−$3.32M	0
Tilton John	Chief Commercial Officer	Oct 03	Disposition to Issuer · D	−1,614	$148.50	−$240K	0
Tilton John	Chief Commercial Officer	Oct 03	Disposition to Issuer · D	−5,068	$148.50	−$753K	1,614
Mehta Kishan	Director	Oct 03	Disposition to Issuer · D	−10,640	$148.50	−$1.58M	0
Buten Matthew	Chief Financial Officer	Oct 03	Disposition to Issuer · D	−6,177	$148.50	−$917K	0
Bailey Gregory	Director	Aug 19	Open-market buy · P	+38,000	$148.04	+$5.63M	2,583,658

Page 1 of 28 · showing the 20 most recent Sign up free to view all 552 transactions and filter by insider →

Comments